Screener
Neuropace, Inc. NPCE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s accounts payable?
- Neuropace, Inc. (NPCE) reported accounts payable of $4.2M in Q2 2026.
- How has Neuropace, Inc.'s accounts payable changed year-over-year?
- Neuropace, Inc.'s accounts payable decreased by 11.0% year-over-year, from $4.72M to $4.2M.
- What is the long-term trend for Neuropace, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s accounts payable has grown at a 31.3% compound annual growth rate (CAGR), from $5.08M to $15.13M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Neuropace, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude